# FDA 483 - Lisa Connery - January 08, 2026

Source: https://www.keypedia.com/records/483/lisa-connery/2c024e1e-1876-4ad6-8eb9-0abb642b73db

> FDA 483 for Lisa Connery on January 08, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lisa Connery
- Inspection Date: 2026-01-08
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: An FDA inspection of Lisa Connery, a clinical investigator in Norman, OK, revealed a significant deviation from the investigational plan. Site staff mistakenly provided incorrect dosing instructions to multiple study participants for an investigational product, leading to subjects receiving an unintended dose. This indicates a failure to conduct the investigation in accordance with the approved protocol.

## Related Officers

- [Joanne M. Schlossin](https://www.keypedia.com/people/joanne-m-schlossin/5cb48b8a-d885-4b4f-8c60-d4714d65603d)

Company: https://www.keypedia.com/companies/lisa-connery/3f19a325-452f-49c0-866d-9cc1a67d58af

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9